VIVIENNE MITCHELL

One Big Beautiful Bill Act/Budget Reconciliation (H.R.1) Tariff proposed policies LIFO accounting method Global Intangible Low-taxed Income (GILTI)

Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). CMS Proposed Medicare Physician Fee Schedule Rule Protecting Patient Access to Cancer and Complex Therapies Act 2025 Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages

Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426)- Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA)

Strategic National Stockpile. Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R. 2483/S.2121) Medical Supply Resiliency Act National Defense Authorization Act FY2026 (NDAA) Supply Chain Resiliency Most Favored Nation drug pricing proposals One Big Beautiful Bill Act / Budget Reconciliation (H.R.1) CMS Proposed Medicare Physician Fee Schedule Rule

Ensuring Community Access to Pharmacist Services Act (H.R. 3164) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Protecting Patient Access to Cancer and Complex Therapies Act 2025 Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages

Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164) Impacts to pharmacy Part D drug pricing in IRA

The Equitable Community Access to Pharmacist Services Act Inflation Reduction Act Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act Seniors Access to Critical Medicines Act (H.R. 2484) Protecting Patient Access to Cancer and Complex Therapies Act Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages

Pharmacy and Medically Underserved Area Enhancement Act Preventing and Mitigating Generic Drug Shortages The Equitable Community Access to Pharmacist Services Act Seniors Access to Critical Medications Act (H.R. 2484)

Tax Cuts and Jobs Act of 2017. LIFO accounting method

Proposed modifications to the existing definition of distributor bona fide service fees The Equitable Community Access to Pharmacist Services Act (H.R. 1770/ S.2477) Inflation Reduction Act Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act (S.1491). Seniors Access to Critical Medicines Act (H.R. 5526/S.3458). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages Senate Finance Draft Medicare Drug Shortage Prevention Policies

Proposed modifications to the existing definition of distributor bona fide service fees The Equitable Community Access to Pharmacist Services Act (H.R. 1770/ S.2477). Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act (S.1491). Seniors Access to Critical Medicines Act (H.R. 5526/S.3458). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages Senate Finance Draft Medicare Drug Shortage Prevention Policies

Tax Cuts and Jobs Act of 2017. LIFO accounting method. U.S. corporate tax rate. H.R. 4355/S.2829 the Rural Veterinary Workforce Act.

Strategic National Stockpile. Essential Medicines Strategic Stockpile Act (H.R.405). Ensuring essential medication supply for military and Department of Defense. Digital communication of prescribing information. Prescription Information Modernization Act (H.R.1503/S.2916). Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). Drug Supply Chain Security Act Implementation (DSCSA). Rolling Active Pharmaceutical Ingredient and Drug (RAPID) Reserve Act (S.2510/H.R.6802). SUPPORT Act Reauthorization (S.2433/H.R.4531). FY2025 National Defense Authorization Act. House E&C Drug Shortages Discussion Draft. FY 2024 Continuing Resolution. Seniors Access to Critical Medications Act of 2023 (H.R. 5526) Department of Defense Essential Medicines Strategic Stockpile Amendment to NDAA Health Care Cybersecurity Improvement Act of 2024 (S.4054)

Tax Cuts and Jobs Act of 2017. LIFO accounting method. U.S. corporate tax rate. H.R. 4355/S.2829 the Rural Veterinary Workforce Act.

Proposed modifications to the existing definition of distributor bona fide service fees The Equitable Community Access to Pharmacist Services Act (H.R. 1770/ S.2477). Inflation Reduction Act. Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act (S.1491). Seniors Access to Critical Medicines Act (H.R. 5526/S.3458). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages. Part B drug pricing changes. Enhanced Oncology Model (EOM). Preventing and Mitigating Generic Drug Shortages: Policy Options Senate Finance Draft Medicare Drug Shortage Prevention Policies Medicaid Stacking Issues

Tax Cuts and Jobs Act of 2017. LIFO accounting method. U.S. corporate tax rate.

Tax Cuts and Jobs Act of 2017. LIFO accounting method. U.S. corporate tax rate.

Medicare Part B Reimbursement. Average Sales Price (ASP). Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees The Equitable Community Access to Pharmacist Services Act (H.R. 1770/ S.2477). Inflation Reduction Act. Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act (S.1491). Seniors Access to Critical Medicines Act (H.R. 5526/S.3458). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages. Part B drug pricing changes. Enhanced Oncology Model (EOM).

Medicare Part B Reimbursement. Average Sales Price (ASP) generally (in the context of deficit reduction). Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Recognizing pharmacists as providers within Medicare for COVID-19 response. The Equitable Community Access to Pharmacist Services Act (H.R. 1770). Inflation Reduction Act. Supporting Medicare Providers Act (H.R.8800). Medicare Access & CHIP Reauthorization Act (MACRA). Pharmacy and Medically Underserved Areas Enhancement Act. Seniors Access to Critical Medicines Act (H.R. 5526). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages.

Legislation to provide for coverage under Medicare program of pharmacist services. Pharmacy and Medically Underserved Area Enhancement Act. Medication therapy management. Legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. House and Senate Agriculture, FDA, and related agency Appropriations bills. House and Senate Labor/HHS appropriations bills. Prescription drug importation. Issues and policies related to generic drug shortages. Recognizing pharmacists as providers within Medicare for COVID-19 response. The Equitable Community Access to Pharmacist Services Act (H.R. 1770/S.2477) and permanent extension of PREP Act Declarations for pharmacist clinical services.

Advancing Emergency Preparedness through One Health Act. Strengthening Americas Strategic National Stockpile Act. Essential Medicines Strategic Stockpile Act. Ensuring essential medication supply for military and Department of Defense. National Defense Authorization Act. digital communication of prescribing information. Prescription Information Modernization Act. Implementation of Consolidated Appropriations Act. Drug Shortages. H.R. 501 - Block, Report and Suspend Suspicious Shipments Act. Pandemic and All Hazards Preparedness Reauthorization. FDA Risk Evaluation and Mitigation Strategy (REMS) and Distribution of FDA-Approved Womens Health Medication. Drug Supply Chain Security Act Implementation. SUPPORT Act Reauthorization. FY 2024 National Defense Authorization Act. Medical and Health Stockpile Accountability Act of 2023 (H.R.3577). Drug Origin Transparency Act of 2023 (H.R. 3810). E&C and Finance Request for Information to Inform Policymaking on Drug Shortages

Medicare Part B Reimbursement. Average Sales Price (ASP) generally (in the context of deficit reduction). International Pricing Index Model. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Recognizing pharmacists as providers within Medicare for COVID-19 response. The Equitable Community Access to Pharmacist Services Act (H.R. 1770). Most Favored Nation (MFN) policy. Inflation Reduction Act. Supporting Medicare Providers Act (H.R.8800). Medicare Access & CHIP Reauthorization Act (MACRA). Pharmacy and Medically Underserved Areas Enhancement Act.

Advancing Emergency Preparedness through One Health Act. Strengthening Americas Strategic National Stockpile Act. Essential Medicines Strategic Stockpile Act. Ensuring essential medication supply for military and Department of Defense. National Defense Authorization Act. digital communication of prescribing information. Prescription Information Modernization Act. Implementation of Consolidated Appropriations Act. Drug Shortages. H.R. 501 - Block, Report and Suspend Suspicious Shipments Act. Pandemic and All Hazards Preparedness Reauthorization. FDA Risk Evaluation and Mitigation Strategy (REMS) and Distribution of FDA-Approved Womens Health Medication. Drug Supply Chain Security Act Implementation.

Legislation to provide for coverage under Medicare program of pharmacist services. Pharmacy and Medically Underserved Area Enhancement Act. Medication therapy management. Legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. House and Senate Agriculture, FDA, and related agency Appropriations bills. House and Senate Labor/HHS appropriations bills. Prescription drug importation. Pharmacy DIR Reform To Reduce Senior Drug Costs Act. Issues and policies related to generic drug shortages. Recognizing pharmacists as providers within Medicare for COVID-19 response. The Equitable Community Access to Pharmacist Services Act (H.R. 1770). Paycheck Protection Program and Health Care Enhancement Act. Federal Retail Pharmacy Partnership for COVID-19 vaccine. Permanent Extension of PREP Act Declarations. The Ensuring Seniors Access to Local Pharmacies Act. S. 113 - Prescription Pricing for the People Act of 2023. Long-Term Care Pharmacy Definition Act.

Advancing Emergency Preparedness through One Health Act. Strengthening Americas Strategic National Stockpile Act. Essential Medicines Strategic Stockpile Act. Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act (PREVENT Pandemics Act). Ensuring essential medication supply for military and Department of Defense. National Defense Authorization Act. Pre-approval Information Exchange Act (H.R. 7008). Modernizing digital communication of prescribing information. Prescription Information Modernization Act. Federal Contracting for Peace and Security Act. Consolidated Appropriations Act (H.R. 2617). Drug Shortages.

Legislation to provide for coverage under Medicare program of pharmacist services. Pharmacy and Medically Underserved Area Enhancement Act. Medication therapy management. Legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. House and Senate Agriculture, FDA, and related agency Appropriations bills. Prescription drug importation. Pharmacy DIR Reform To Reduce Senior Drug Costs Act. Issues and policies related to generic drug shortages. Recognizing pharmacists as providers within Medicare for COVID-19 response. The Equitable Community Access to Pharmacist Services Act (H.R. 7213). Paycheck Protection Program and Health Care Enhancement Act. Federal Retail Pharmacy Partnership for COVID-19 vaccine. American Rescue Plan. Permanent Extension of PREP Act Declarations. The Ensuring Seniors Access to Local Pharmacies Act. S.1388 - Prescription Pricing for the People Act of 2021. Long-Term Care Pharmacy Definition Act.

Advancing Emergency Preparedness through One Health Act. Strengthening Americas Strategic National Stockpile Act. Essential Medicines Strategic Stockpile Act. Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act (PREVENT Pandemics Act). Ensuring essential medication supply for military and Department of Defense. National Defense Authorization Act. Pre-approval Information Exchange Act (H.R. 7008). Modernizing digital communication of prescribing information. Prescription Information Modernization Act. Federal Contracting for Peace and Security Act.

Legislation to provide for coverage under Medicare program of pharmacist services. Pharmacy and Medically Underserved Area Enhancement Act. Medication therapy management. Legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. House and Senate Agriculture, FDA, and related agency Appropriations bills. Prescription drug importation. Pharmacy DIR Reform To Reduce Senior Drug Costs Act. Issues and policies related to generic drug shortages. Recognizing pharmacists as providers within Medicare for COVID-19 response. The Equitable Community Access to Pharmacist Services Act (H.R. 7213). Paycheck Protection Program and Health Care Enhancement Act. Federal Retail Pharmacy Partnership for COVID-19 vaccine. American Rescue Plan. Permanent Extension of PREP Act Declarations. The Ensuring Seniors Access to Local Pharmacies Act. S.1388 - Prescription Pricing for the People Act of 2021. Long-Term Care Pharmacy Definition Act.

Advancing Emergency Preparedness through One Health Act. Strengthening Americas Strategic National Stockpile Act. Essential Medicines Strategic Stockpile Act. Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act (PREVENT Pandemics Act). Ensuring essential medication supply for military and Department of Defense. National Defense Authorization Act. Pre-approval Information Exchange Act (H.R. 7008). Modernizing digital communication of prescribing information. Prescription Information Modernization Act.

Legislation to provide for coverage under Medicare program of pharmacist services. Pharmacy and Medically Underserved Area Enhancement Act. Medication therapy management. Legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. House and Senate Agriculture, FDA, and related agency Appropriations bills. Prescription drug importation. Pharmacy DIR Reform To Reduce Senior Drug Costs Act. Issues and policies related to generic drug shortages. Recognizing pharmacists as providers within Medicare for COVID-19 response. The Equitable Community Access to Pharmacist Services Act (H.R. 7213). Paycheck Protection Program and Health Care Enhancement Act. Federal Retail Pharmacy Partnership for COVID-19 vaccine. American Rescue Plan. Permanent Extension of PREP Act Declarations. The Ensuring Seniors Access to Local Pharmacies Act. S.1388 - Prescription Pricing for the People Act of 2021. Long-Term Care Pharmacy Definition Act.

Legislation to provide for coverage under Medicare program of pharmacist services. Pharmacy and Medically Underserved Area Enhancement Act. Medication therapy management. Legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. House and Senate Agriculture, FDA, and related agency Appropriations bills. Prescription drug importation. Phair Pricing Act. Pharmacy DIR Reform To Reduce Senior Drug Costs Act. Issues and policies related to generic drug shortages. Recognizing pharmacists as providers within Medicare for COVID-19 response. The Equitable Community Access to Pharmacist Services Act (H.R. 7213). Paycheck Protection Program and Health Care Enhancement Act. Federal Retail Pharmacy Partnership for COVID-19 vaccine. American Rescue Plan. Permanent Extension of PREP Act Declarations. The Ensuring Seniors Access to Local Pharmacies Act. S.1388 - Prescription Pricing for the People Act of 2021. Long-Term Care Pharmacy Definition Act.

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Recognizing pharmacists as providers within Medicare for COVID-19 response. The Equitable Community Access to Pharmacist Services Act (H.R. 7213). Paycheck Protection Program and Health Care Enhancement Act. Most Favored Nation (MFN) policy. Medicare Sequester Relief Act (H.R. 1868). American Rescue Plan. The Bolstering Innovative Options to Save Immediately on Medicines (BIOSIM) Act (H.R. 2815). Build Back Better Act. Protecting Medicare and American Farmers from Sequester Cuts Act.

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program and Health Care Enhancement Act. Most Favored Nation (MFN) policy. Medicare Sequester Relief Act (H.R. 1868). American Rescue Plan. The Bolstering Innovative Options to Save Immediately on Medicines (BIOSIM) Act (H.R. 2815). Build Back Better Act. Protecting Medicare and American Farmers from Sequester Cuts Act.

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program and Health Care Enhancement Act. Most Favored Nation (MFN) policy. Medicare Sequester Relief Act (H.R. 1868). American Rescue Plan. The Bolstering Innovative Options to Save Immediately on Medicines (BIOSIM) Act (H.R. 2815).

Advancing Emergency Preparedness through One Health Act. COVID-19 vaccine Distribution. Strengthening Americas Strategic National Stockpile Act. Essential Medicines Strategic Stockpile Act.

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program and Health Care Enhancement Act. Most Favored Nation (MFN) policy. Medicare Sequester Relief Act (H.R. 1868). American Rescue Plan. The Bolstering Innovative Options to Save Immediately on Medicines (BIOSIM) Act (H.R. 2815).

Legislation to provide for coverage under Medicare program of pharmacist services. Pharmacy and Medically Underserved Area Enhancement Act. Medication therapy management. Legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. House and Senate Agriculture, FDA, and related agency Appropriations bills. Prescription drug importation. Phair Pricing Act. Pharmacy DIR Reform To Reduce Senior Drug Costs Act. DEA Order Clearinghouse Act. John S. McCain Opioid Addiction Prevent Act. Issues and policies related to generic drug shortages. Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program and Health Care Enhancement Act. Federal Retail Pharmacy Partnership for COVID-19 vaccine. American Rescue Plan. Permanent Extension of PREP Act Declarations. The Ensuring Seniors Access to Local Pharmacies Act.

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. Legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. House and Senate Agriculture, FDA, and related agency Appropriations bills. Prescription drug importation. Phair Pricing Act. DEA Order Clearinghouse Act John S. McCain Opioid Addiction Prevent Act. Issues and policies related to generic drug shortages. Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program Flexibility Act of 2020. Paycheck Protection Program and Health Care Enhancement Act. Federal Retail Pharmacy Partnership for COVID-19 vaccine. American Rescue Plan. Permanent Extension of PREP Act Declarations.

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program Flexibility Act of 2020. Paycheck Protection Program and Health Care Enhancement Act. Most Favored Nation (MFN) policy. Medicare Sequester Relief Act (H.R. 1868). American Rescue Plan.

Advancing Emergency Preparedness through One Health Act. The Consolidated Appropriations Act of 2021 (H.R. 133). COVID-19 vaccine distribution

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. S. 2543 The Prescription Drug Pricing Reduction Act of 2019. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Coronavirus Aid, Relief and Economic Security Act (CARES Act). Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program Flexibility Act of 2020. Paycheck Protection Program and Health Care Enhancement Act. Most Favored Nation (MFN) policy. Extension of Medicare sequestration relief.

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. S. 988 and H.R. 803, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. House and Senate Agriculture, FDA, and related agency Appropriations bills. Prescription drug importation. H.R. 1034 and S. 640, Phair Pricing Act. DEA Order Clearinghouse Act (H.R. 6600, S. 3282 - 115th Congress). H.R. 1607 - Fairness to Pet Owners Act of 2019. S.724 and H.R. 1614 John S. McCain Opioid Addiction Prevent Act. Issues related to drug shortages. Coronavirus Aid, Relief and Economic Security Act (CARES Act). Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program Flexibility Act of 2020. Paycheck Protection Program and Health Care Enhancement Act

Advancing Emergency Preparedness through One Health Act

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. S. 2543 The Prescription Drug Pricing Reduction Act of 2019. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Coronavirus Aid, Relief and Economic Security Act (CARES Act). Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program Flexibility Act of 2020. Paycheck Protection Program and Health Care Enhancement Act

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. S. 2543 The Prescription Drug Pricing Reduction Act of 2019. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Coronavirus Aid, Relief and Economic Security Act (CARES Act)

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. S. 988 and H.R. 803, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House and Senate Agriculture, FDA, and related agency Appropriations bills; H.R. 1959, Preserving Patient Access to Compounded Medications. Prescription drug importation. H.R. 1034 and S. 640, Phair Pricing Act. DEA Order Clearinghouse Act (H.R. 6600, S. 3282 - 115th Congress). H.R. 1607 - Fairness to Pet Owners Act of 2019. S.724 and H.R. 1614 John S. McCain Opioid Addiction Prevent Act. Issues related to drug shortages. Coronavirus Aid, Relief and Economic Security Act (CARES Act)

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. S. 2543 The Prescription Drug Pricing Reduction Act of 2019. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B.

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. S. 988 and H.R. 803, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House and Senate Agriculture, FDA, and related agency Appropriations bills; H.R. 1959, Preserving Patient Access to Compounded Medications. Prescription drug importation. H.R. 1034 and S. 640, Phair Pricing Act. DEA Order Clearinghouse Act (H.R. 6600, S. 3282 - 115th Congress). H.R. 1607 - Fairness to Pet Owners Act of 2019. S.724 and H.R. 1614 John S. McCain Opioid Addiction Prevent Act.

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. S. 988 and H.R. 803, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House and Senate Agriculture, FDA, and related agency Appropriations bills; H.R. 1959, Preserving Patient Access to Compounded Medications. Prescription drug importation. H.R. 1034 and S. 640, Phair Pricing Act. DEA Order Clearinghouse Act (H.R. 6600, S. 3282 - 115th Congress). H.R. 1607 - Fairness to Pet Owners Act of 2019. S.724 and H.R. 1614 John S. McCain Opioid Addiction Prevent Act.

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. S. 2543 The Prescription Drug Pricing Reduction Act of 2019. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B.

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. Medicare Part B Biosimilar Reimbursement.

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. S. 988 and H.R. 803, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House and Senate Agriculture, FDA, and related agency Appropriations bills; H.R. 1959, Preserving Patient Access to Compounded Medications. Prescription drug importation. H.R. 1034, Phair Pricing Act. DEA Order Clearinghouse Act (H.R. 6600, S. 3282 - 115th Congress). H.R. 1607 - Fairness to Pet Owners Act of 2019. S.724 John S. McCain Opioid Addiction Prevent Act.

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. S. 988 and H.R. 803, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House and Senate Agriculture, FDA, and related agency Appropriations bills; H.R. 1959, Preserving Patient Access to Compounded Medications. Prescription drug importation. H.R. 1034, Phair Pricing Act. DEA Order Clearinghouse Act (H.R. 6600, S. 3282 - 115th Congress). H.R. 1607 - Fairness to Pet Owners Act of 2019.

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program.

S. 483 (114th Congress) legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 109, provide for coverage under Medicare program of pharmacist services. Medication Therapy Management. H.R. 1038 and S. 413, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017. Prescription Drug Importation including S. 771 and H.R. 1776, the Improving Access to Affordable Prescription Drugs Act and S.469, the Affordable and Safe Prescription Drug Importation Act. E-Prescribing bills including H.R. 3528 and S. 2460, the Every Prescription Conveyed Securely (EPCS) Act. H.R. 5958, Phair Pricing Act of 2018. HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. S. 3282 and H.R. 6600, the DEA Order Clearinghouse Act of 2018. H.R. 6, SUPPORT for Patients and Communities Act.

H.R. 1920 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts.

Implementation of the Veterinarian Food Directive; Antimicrobial Resistance.

S. 483 (114th Congress) legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 109, provide for coverage under Medicare program of pharmacist services. Medication Therapy Management. H.R. 1038 and S. 413, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017. Prescription Drug Importation including S. 771 and H.R. 1776, the Improving Access to Affordable Prescription Drugs Act and S.469, the Affordable and Safe Prescription Drug Importation Act. E-Prescribing bills including H.R. 3528 and S. 2460, the Every Prescription Conveyed Securely (EPCS) Act. H.R. 5958, Phair Pricing Act of 2018. HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. S. 3282 and H.R. 6600, the DEA Order Clearinghouse Act of 2018.

H.R. 1920 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts.

S. 483 (114th Congress) legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 109, provide for coverage under Medicare program of pharmacist services. Medication Therapy Management. H.R. 1038 and S. 413, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017. Prescription Drug Importation including S. 771 and H.R. 1776, the Improving Access to Affordable Prescription Drugs Act and S.469, the Affordable and Safe Prescription Drug Importation Act. E-Prescribing bills including H.R. 3528 and S. 2460, the Every Prescription Conveyed Securely (EPCS) Act. H.R. 5958, Phair Pricing Act of 2018. HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.

Implementation of the Veterinarian Food Directive; Antimicrobial Resistance.

H.R. 1920 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts.

S. 483 (114th Congress) legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 109, provide for coverage under Medicare program of pharmacist services. Medication Therapy Management. H.R. 1038 and S. 413, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017. Prescription Drug Importation including S. 771 and H.R. 1776, the Improving Access to Affordable Prescription Drugs Act and S.469, the Affordable and Safe Prescription Drug Importation Act. E-Prescribing bills including H.R. 3528 and S. 2460, the Every Prescription Conveyed Securely (EPCS) Act.

Implementation of the Veterinarian Food Directive; Antimicrobial Resistance.

S. 483 (114th Congress) legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 109, provide for coverage under Medicare program of pharmacist services. Medication Therapy Management H.R. 10385 and S. 413, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017. Prescription Drug Importation including S. 771 and H.R. 1776, the Improving Access to Affordable Prescription Drugs Act and S.469, the Affordable and Safe Prescription Drug Importation Act S. 413 and H.R. 1038 Medicare Part D and Pharmacy Reimbursement.

Implementation of the Veterinarian Food Directive; Antimicrobial Resistance.

H.R. 1920 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts. H.R. 1834 & S. 463, The Cancer Care Payment Reform Act of 2017. CMS, OMB, HHS, White House Domestic Policy Council, Medicare Part B Reimbursement, Medicare Part D Pharmacy Reimbursement.

Enactment of S.483 (114th Congress)legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 109, Provide for coverage under Medicare program of pharmacist services. Medication Therapy Management H.R. 1038 and S. 413, legislation to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act Prescription Drug Importation including S.771 & H.R. 1776, the Improving Access to Affordable Prescription Drugs Act and S. 469, the Affordable and Safe Prescription Drug Importation Act. S. 413 and H.R. 1038 Medicare Part D and Pharmacy Reimbursement.

Implementation of the Veterinarian Food Directive; Antimicrobial Resistance.

Repeal of LIFO (last in, first out).

H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Oncology Innovation Project - Center for Medicare and Medicaid Innovation. Sequestration cuts to cancer care. H.R. 1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.

H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts. S. 1277, S. 1657, H.R. 3392 & H.R. 4096 legislation to prevent and reduce prescription drug abuse.H.R. 4190, Provide for coverage under Medicare program of pharmicist services

H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Oncology Innovation Project - Center for Medicare and Medicaid Innovation. Sequestration cuts to cancer care.H.R. 1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.

Repeal of LIFO (last in, first out).

H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts. S. 1277, S. 1657 & H.R. 3392 legislation to prevent and reduce prescription drug abuse.H.R. 1919, H.R. 3204, S. 957 & S. 959, Pharmaceutical pedigree anti-counterfeiting legislation and provisions affecting pharmaceutical compounding. Legislation pertaining to drug manufacturing shortages.

H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Oncology Innovation Project - Center for Medicare and Medicaid Innovation. Sequestration cuts to cancer care.H.R. 1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.

H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1416 Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.H.R. 1919, H.R. 3204, S. 957 & S. 959, Pharmaceutical pedigree anti-counterfeiting legislation and provisions affecting pharmaceutical compounding. Legislation pertaining to drug manufacturing shortages.

Repeal of LIFO (last in, first out).

H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Oncology Innovation Project - Center for Medicare and Medicaid Innovation. Sequestration cuts to cancer care

H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1919 & S. 957, Pharmaceutical pedigree anti-counterfeiting legislation. Legislation pertaining to drug manufacturing shortages.

H.R. 800 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Pharmaceutical pedigree anti-counterfeiting legislation. Legislation pertaining to drug manufacturing shortages.

H.R. 800 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Oncology Innovation Project - Center for Medicare and Medicaid Innovation. Sequestration cuts to cancer care

H.R. 905 and S. 733 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. ASP Generally (in the context of Deficit Reduction). Oncology Innovation Project - Center for Medicare and Medicaid Innovation.

H.R. 905 and S. 733 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1483, Drug Safety Enhancement Act of 2011, provisions related to pharmaceutical pedigree, wholesale transaction documentation, and electronic tracking. H.R. 3026, Safeguarding America's Pharmaceuticals Act, provisions related to pharmaceutical pedigree anti-counterfeiting. S. 1584, Drug Safety and Accountability Act of 2011, provisions related to pharmaceutical pedigree anti-counterfeiting. Preserving Access to Life-Saving Medications Act (H.R. 2245, S. 296), provisions related to drug shortages.

H.R. 905 and S. 733 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. ASP Generally (in the context of Deficit Reduction). Oncology Innovation Project - Center for Medicare and Medicaid Innovation.

Repeal of LIFO (last in, first out).

H.R. 905 and S. 733 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1483, Drug Safety Enhancement Act of 2011, provisions related to pharmaceutical pedigree, wholesale transaction documentation, and electronic tracking. H.R. 3026, Safeguarding America's Pharmaceuticals Act, provisions related to pharmaceutical pedigree anti-counterfeiting. S. 1584, Drug Safety and Accountability Act of 2011, provisions related to pharmaceutical pedigree anti-counterfeiting. Preserving Access to Life-Saving Medications Act (H.R. 2245, S. 296), provisions related to drug shortages.

H.R. 905 and S. 733 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. ASP Generally (in the context of Deficit Reduction). Oncology Innovation Project - Center for Medicare and Medicaid Innovation.

Repeal of LIFO (last in, first out).

H.R. 905 and S. 733 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1483, Drug Safety Enhancement Act of 2011, provisions related to pharmaceutical pedigree, wholesale transaction documentation, and electronic tracking. H.R. 3026, Safeguarding America's Pharmaceuticals Act, provisions related to pharmaceutical pedigree anti-counterfeiting. S. 1584, Drug Safety and Accountability Act of 2011, provisions related to pharmaceutical pedigree anti-counterfeiting. Preserving Access to Life-Saving Medications Act (H.R. 2245, S. 296), provisions related to drug shortages.

H.R. 905 and S. 733 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1483, Drug Safety Enhancement Act of 2011, provisions related to pharmaceutical pedigree, wholesale transaction documentation, and electronic tracking. H.R. 3026, Safeguarding America's Pharmaceuticals Act, provisions related to pharmaceutical pedigree anti-counterfeiting. S. 1584, Drug Safety and Accountability Act of 2011, provisions related to pharmaceutical pedigree anti-counterfeiting. Preserving Access to Life-Saving Medications Act (H.R. 2245, S. 296), provisions related to drug shortages.

H.R. 905 and S. 733 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. ASP Generally (in the context of Deficit Reduction).

H.R. 905 and S. 733 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1483, Drug Safety Enhancement Act of 2011, provisions related to pharmaceutical pedigree, wholesale transaction documentation, and electronic tracking. H.R. 3026, Safeguarding America's Pharmaceuticals Act, provisions related to pharmaceutical pedigree anti-counterfeiting. S. 1584, Drug Safety and Accountability Act of 2011, provisions related to pharmaceutical pedigree anti-counterfeiting. Preserving Access to Life-Saving Medications Act (H.R. 2245, S. 296), provisions related to drug shortages.

H.R. 905 and S. 733 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. ASP Generally (in the context of Deficit Reduction).

H.R. 905 and S. 733 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1483, Drug Safety Enhancement Act of 2011, provisions related to pharmaceutical pedigree, wholesale transaction documentation, and electronic tracking. H.R. 3026, Safeguarding America's Pharmaceuticals Act, provisions related to pharmaceutical pedigree anti-counterfeiting. S. 1584, Drug Safety and Accountability Act of 2011, provisions related to pharmaceutical pedigree anti-counterfeiting. Preserving Access to Life-Saving Medications Act (H.R. 2245, S. 296), provisions related to drug shortages.

H.R. 905 and S. 733 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.

Repeal of LIFO (last in, first out).

H.R. 905 and S. 733 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.

H.R. 905 and S. 733 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.

Importation, Drug Safety, Medicaid and Medicare Reimbursement, Medicare Prompt Pay Discount Exclusion, Budget Act, Pharmaceutical Pedigree Anti-Counterfeiting, Drug Shortages, Tax (Repeal of LIFO (last in, first out))

Importation, Drug Safety, Medicaid and Medicare Reimbursement, Medicare Prompt Pay Discount Exclusion, Budget Act, Pharmaceutical Pedigree Anti-Counterfeiting, Drug Shortages, Tax (Repeal of LIFO (last in, first out))

Importation, Drug Safety, Medicaid and Medicare Reimbursement, Medicare Prompt Pay Discount Exclusion, Budget Act, Pharmaceutical Pedigree Anti-Counterfeiting, Drug Shortages, Tax (Repeal of LIFO (last in, first out))